Empowering Medicare Seniors to Negotiate Drug Prices Act of 2021

Hozzl · 2023-01-11T13:47:39Z

Explore the details of Senate Bill 833 Empowering Medicare Seniors to Negotiate Drug Prices Act of 2021 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

1/11/2023, 1:47 PM

Congressional Summary of S 833

Empowering Medicare Seniors to Negotiate Drug Prices Act of 2021

This bill allows the Centers for Medicare & Medicaid Services to negotiate drug prices under the Medicare prescription drug benefit and to institute a price structure for the reimbursement of drugs covered under the benefit.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 833

Bill S 833 is currently in the status of Bill Introduced since March 18, 2021. Bill S 833 was introduced during Congress 117 and was introduced to the Senate on March 18, 2021. Bill S 833's most recent activity was Read twice and referred to the Committee on Finance. as of March 18, 2021

Bipartisan Support of Bill S 833

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 833

Primary Policy Focus

Health

Potential Impact Areas

- Health care costs and insurance

- Inflation and prices

- Medicare

- Prescription drugs

- Public contracts and procurement

Alternate Title(s) of Bill S 833

Empowering Medicare Seniors to Negotiate Drug Prices Act of 2021

A bill to amend XVIII of the Social Security Act to allow the Secretary of Health and Human Services to negotiate fair prescription drug prices under part D of the Medicare program.

Empowering Medicare Seniors to Negotiate Drug Prices Act of 2021